focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

16 Aug 2010 08:50

RNS Number : 1119R
Phorm Inc
16 August 2010
 



16th August 2010

Phorm, Inc. ('Phorm' or 'the Company')

 

Phorm Announces Board Changes

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, announces the following changes to the Company's Board:

 

Mark Schneider is appointed to the Board as a Non-Executive Director. Mark was co-founder of leading European cable group UPC, which was subsequently acquired by Liberty Global in 2005. Mark has served on public and private company boards of companies operating in over 20 countries around the world, including United Artist Entertainment, UIH, UnitedGlobalCom, UPC, SBS Broadcasting and Blockbuster Video. With his background in international cable and telecommunications, Mark brings strong operating knowledge and an extensive network of contacts to the Board.

 

Kip Meek will step down from the Board with immediate effect. This follows Kip's previously announced appointment as Chairman of Project Canvas.

 

Kent Ertugrul, CEO of Phorm, commented, "I would like to thank Kip for his valuable insights and advice, which have contributed to the progress made by the Company since his appointment. We are sorry to see Kip go, but recognise that he needs to focus his energies on Project Canvas. We wish him well.

 

Meanwhile, we welcome Mark Schneider to the Board. He brings with him an in-depth understanding of media and telecommunications, has operated in multiple markets globally, and remains one of the pioneers of the international cable industry. We look forward to working with Mark to deliver on the substantial promise of our Company."

 

Save as set out in the Appendix, there are no further details in relation to the above appointment which require disclosure under paragraph (g) of Schedule 2 to the AIM rules.

 

Enquiries:

 

Phorm, Inc

Sarah Simon: +44 20 7297 2433 (analysts and investors)

Alex Laity: +44 20 7297 2710 (press)

 

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

 

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Adviser)

Mark Williams

Andrew Chubb

 

 

Appendix:

 

Information provided in accordance with paragraph g of Schedule 2 to the AIM rules:

 

1. Details of full name, age, previous names:

 

Full Name: Mark Lyle Schneider

Age: 55

 

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner

 

General Media Services Limited - present

Schneider Media Africa Limited - present

Africa Telecommunications Media and Technology Fund 1 LLC - present

Big Sleep Hotels - present

Ricall Limited - present

Shorts Entertainment Limited - present

 

In addition, Mr Schneider has, in relation to this appointment as a Non-Executive Director, today been granted options over 150,000 shares of USD 0.001 each in the Company ("Ordinary Shares"), exercisable at a price of 137.5p per Ordinary Share. These options have a vesting period of four years, and expire ten years from the Date of Grant. Following this grant, Mr Schneider will have options over 200,000 Ordinary Shares.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADMGMRNVLGGZG
Date   Source Headline
19th Jun 20127:00 amRNSAGM Statement
1st Jun 20127:00 amRNS£20m equity fundraising into Phorm China
1st Jun 20127:00 amRNSIntention to Re-Domicile
22nd May 20127:00 amRNSPhorm Announces AGM Notice & Proposed Board Change
21st Mar 20127:00 amRNSAppointment of Nominated Adviser and Joint Broker
5th Mar 20127:00 amRNSTransfer of Shares
1st Mar 20127:00 amRNSTransfer of Shares
28th Dec 20117:00 amRNSDirector Dealing
12th Dec 201110:10 amRNSTransfer of Shares
7th Dec 201110:19 amRNSTransfer of Shares
2nd Dec 20112:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Dec 201112:16 pmRNSTransfer of Shares
11th Nov 20117:30 amRNSIssue of Equity
4th Nov 20117:30 amRNSIssue of Equity
21st Oct 20113:28 pmRNSIssue of Equity
20th Oct 20114:14 pmRNSTransfer of Shares
7th Oct 20112:00 pmRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results for Six Months Ended 30 June 2011
28th Sep 20117:00 amRNSProduct Launch
30th Jun 20117:00 amRNSAnnual Financial Report
8th Apr 201112:00 pmRNSBlock Admission Return
30th Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares
22nd Mar 20117:00 amRNSPlacing and operating update
2nd Mar 201112:00 pmRNSTransfer of Shares
1st Feb 201110:14 amRNSResult of AGM
6th Jan 20117:15 amRNSOption Grant and Modification
6th Jan 20117:05 amRNSAdvisory Board Appointment - Juan Villalonga
24th Dec 20108:11 amRNSNotice of AGM
17th Dec 20109:11 amRNSIssue of convertible secured loan notes
8th Oct 20105:25 pmRNSBlock Admission Return
30th Sep 20107:00 amRNSInterim results
22nd Sep 20107:00 amRNSUpdate on Commercial Deployment in Brazil
17th Aug 20103:42 pmRNSCorrection re Share Transfer
16th Aug 20103:58 pmRNSShare Transfer
16th Aug 20108:50 amRNSDirectorate Change
30th Jul 20101:00 pmRNSTransfer of Shares
23rd Jul 201011:17 amRNSDirectorate Change
16th Jul 20104:25 pmRNSTransfer of Shares
9th Jul 20107:00 amRNSTransfer of Shares
7th Jul 20104:55 pmRNSDirector/PDMR Shareholding
7th Jul 20102:19 pmRNSPlacing of Shares
30th Jun 20102:17 pmRNSAnnual Report & Accounts Notification
30th Jun 20107:00 amRNSPreliminary Results
28th Jun 20107:00 amRNSNotification of results
8th Jun 20102:05 pmRNSChange in name of Nominated Adviser
30th Apr 20101:08 pmRNSGrant of options
9th Apr 20105:25 pmRNSBlock Admission Return
26th Mar 20107:00 amRNSCommercial Deployment in Brazil
28th Jan 20104:37 pmRNSNotification of Major Interest in Shares
11th Jan 20104:28 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.